fludarabine has been researched along with B Virus Infection in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bond, R; Brown, M; Campbell, P; Grigg, AP; Ritchie, D; Scarlett, J; Seymour, JF; Tam, C; Underhill, C | 1 |
Campo, E; Gaya, A; Martinez, A; Mercadal, S; Nomdedeu, B; Rozman, M; Salamero, O | 1 |
Byrd, JC; Diehl, LF; Dow, NA; Hospenthal, DR; Howard, RS; McGrail, LH | 1 |
3 other study(ies) available for fludarabine and B Virus Infection
Article | Year |
---|---|
Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Disease Susceptibility; Female; Herpesviridae Infections; Humans; Immunocompromised Host; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pneumonia, Pneumocystis; Risk; Rituximab; Vidarabine | 2005 |
Herpes simplex and Epstein-Barr virus lymphadenitis in a patient with chronic lymphocytic leukemia treated with fludarabine.
Topics: Acyclovir; Aged; Antineoplastic Agents; Antiviral Agents; Female; Gene Expression Profiling; Gene Expression Regulation, Viral; Herpesviridae Infections; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 4, Human; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphadenitis; Vidarabine | 2006 |
Herpes virus infections occur frequently following treatment with fludarabine: results of a prospective natural history study.
Topics: Aged; Female; Herpesviridae Infections; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Middle Aged; Opportunistic Infections; Prospective Studies; Vidarabine | 1999 |